|
||||||||||||||||
| HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
| Engineered Antibody Technologies Accelerating Drug Discovery & Development | ||||||||||||||||
| January 23, 2001 | ||||||||||||||||
|
Strategic Research Institute, Philadelphia, PA USA September 18-19, 2001 For more info contact Glenn Pascual or Ed Drilon at gpascual@srinstitute.com or 212-967-0095, x245 |
||||||||||||||||
| Organized by: | Strategic Research Institute | |||||||||||||||
| Invited Speakers: | Awaiting Responses from: Abbott Labs Agouron Pharmaceuticals AstraZeneca Aventis Bayer Corporation Biogen Inc. Bristol Myers Sqiubb Dupont Pharmaceuticals Co. Eli Lilly & Co. Genentech Inc. Glaxo Wellcome Hoffmann-La Roche Inc. Jannsen Research Foundation Johnson & Johnson Merck & Co. Inc. Medarex Inc. Millenium Pharmaceuticals Novartis Parke Davis Pfizer Inc. Pharmacia Proctor & Gamble Co. Purdue Pharmaceuticals RW Johnson Pharmaceutical Schering Plough Corp. SmithKline & Beecham Wyeth Ayerst among others... |
|||||||||||||||
| Deadline for Abstracts: | May 18, 2001 | |||||||||||||||
| Registration: | Contact Glenn Pascual at 212-967-0095, x245 |
|||||||||||||||
| E-mail: | gpascual@srinstitute.com | |||||||||||||||
| Posted by: | Glenn Pascual and Ed Drilon | |||||||||||||||
| Host: | 12.3.58.10 | |||||||||||||||
|
||||||||||||||||
|
Generated by meetings and positions 5.0 by Kai Garlipp |
||||||||||||||||